Table 1 Descriptive analysis of HCC patients’ characteristics
From: Relation between GSTP1 polymorphism and oxidative stress in patients with hepatocellular carcinoma
Character | No. (%) (N = 99) | |
|---|---|---|
Age (years) | < 54 | 55 (55.6) |
55-56 | 44 (44.4) | |
Gender | Female | 24 (24.2) |
Male | 75 (75.8) | |
Family history of HCC | Negative | 87 (88) |
Positive | 12 (12) | |
Tumor size | ≤ 3 cm | 36 (36.4) |
> 3 cm | 63 (63.6) | |
No. of focal lesions | ≤ 3 | 71 (71.7) |
> 3 | 28 (28.3) | |
Stage (TNM classification) | I | 7 (7.1) |
II | 19 (19.2) | |
IIIA | 30 (30.3) | |
IIIB | 15 (15.2) | |
IVA | 15 (15.2) | |
IVB | 13 (13.1) | |
Stage | Early stage (I, II) | 26 (26.3) |
Late stage (IIIA, IIIB, IVA, IVB) | 73 (73.7) | |
Child score | A5 | 21 (21.1) |
A6 | 32 (32.4) | |
B7 | 18 (18.3) | |
B8 | 10 (9.9) | |
B9 | 15 (15.5) | |
C1 | 3 (2.8) | |
Distant metastasis | No | 87 (86.9) |
Yes | 12 (13.1) | |
Liver cirrhosis | Negative | 2 (2.1) |
Positive | 97 (97.9) | |
Portal vein | Thrombosed | 22 (25.0) |
Patent | 77 (75.0) | |
Splenomegaly | −ve | 38 (38.9) |
+ve | 61 (61.1) | |
Ascites | Present | 35 (35.3) |
Absent | 64 (64.7) | |
Lymph node metastasis | −ve | 76 (76.8) |
+ve | 23 (23.2) | |
HBV infection | B−ve | 96 (97.0) |
B + ve | 3 (3.0) | |
HCV infection | C−ve | 16 (16.2) |
C + ve | 83 (83.8) | |
GSH (μM/mg) (N: 684-2525) | Median | 1916.5 |
Range | (862-3011) |